| Docs Home | Help | Sign out

.

AuthorCompanyLinkDate Posted

.

Social Media and the FDAJodiJust Keep Swimming (blog)http://bit.ly/7IMb2s1/13/2010

.

Will FDA Social Media Regulations Impact the Healthcare Debate? PR Must Take Steps Now to Bring Consumers and Healthcare TogetherDeborah SittigGreen Room Public Relationshttp://bit.ly/8K8ZTi1/7/2010

.

Social Media, Regulatory Guidance and Patent AdvocacyNABioJobBloghttp://bit.ly/5i3ygN12/18/2009

.

Does Pharma + FDA + Social Media = Better ePatient Care? (AUDIO PODCAST)Podcast w/Fard Johnmar and Steve WoodruffPodcast hosted by Toby Bloomberg of Diva Marketing (Bloghttp://bit.ly/81CJeJ12/18/2009

.

Pharma Social Media: Sea Change or Fad?Chris IafollaPRforPharmahttp://bit.ly/4p7b5K12/18/2009

.

New Drug-Advertising Options Confound FDA RegulatorsJun YanPsychiatric Newshttp://bit.ly/5Ps1Ou12/18/2009

.

Patients WILL Have the Final Say on Pharma Social MediaJonathan RichmanBridge Worldwidehttp://bit.ly/8IN71f12/17/2009

.

Answers to Questions from Investors about FDA, Social Media, & Online Pharma AdvertisingJohn MackPharma Marketing Bloghttp://slidesha.re/71SWR512/17/2009

.

FDASM IntroductionPF AndersonEmerging Technologies Librarianhttp://bit.ly/5q1DHE12/15/2009

.

Will Patients Find Value in Discussions with Pharma Marketers on Social Media Sites?John MackPharma Marketing Bloghttp://bit.ly/6tazIh12/15/2009

.

FDA Considers Best Way to Regulate Online ContentNAPharmacyEscrow.comhttp://bit.ly/8VD1JK12/15/2009

.

Social Media and PharmaScott Strangevia TuDiabetes Bloghttp://tinyurl.com/y944png12/15/2009

.

Time to make the case for social media in European health careSilja ChouquetWhydothttp://bit.ly/8JnUw5 12/15/2009

.

What’s Your Pharma Wishlist for 2010?Sven LarsenZemogahttp://bit.ly/5zMicO12/15/2009

.

Pharma, Don’t Be Shy about Social MediaWendy BlackburninTouch Solutionshttp://tr.im/Hm1c12/11/2009

.

Educating Legal and Regulatory Departments Inside Pharmaceutical Companies on Social MediaChris IafollaShift Communicationshttp://tr.im/HgsP12/10/2009

.

Baumann's Call to Arms - Use of Twitter in Healthcare in 2009Phil Baumann (interview)HCPLivehttp://bit.ly/4uLNUR12/9/2009

.

Pharma Social Media Brings Discomfort in Lack of KnowledgeChris IafollaShift Communicationshttp://tr.im/Hgt512/9/2009

.

The FDA, Big Pharma, and Social Media: What's the Right Rx?Bob PearsonWeiscomm PRhttp://tr.im/H8y912/8/2009

.

Pharma: Socializing in a StraightjacketBrian MorrisseyAdWeekhttp://tr.im/GVSc12/7/2009

.

Pharma Marketers Ask FDA For Online Ads - Tweeting Side Effects in 140 Characters Or Less?McKinley BrewerNAhttp://tr.im/H4ki12/7/2009

.

The white elephant in the room: FDA hearing and DTCSilja ChouquetWhydothttp://bit.ly/4U9gom 12/7/2009

.

FDASM Highlights for UM Stakeholders: Most Important Links & Things You Can DoPF AndersonEmerging Technologies Librarianhttp://tr.im/GVVN12/6/2009

.

Social Media & the FDAWendy BlackburnIntouch Solutionshttp://tr.im/GVTL12/6/2009

.

Solutions from the FDA social media hearingsWendy BlackburnIntouch Solutionshttp://tr.im/GVTN12/6/2009

.

Logo? or Loco?Mark Drossmanextrovertichttp://tr.im/GVTF12/5/2009

.

FDASM Highlights for UM Stakeholders, IntroductionPF AndersonEmerging Technologies Librarianhttp://tr.im/GzeQ12/3/2009

.

Promoting FDA–Regulated Medical Products Using the Internet and Social MediaSteven ImmergutHill & Knowltonhttp://tr.im/GzfG12/3/2009

.

Atlas Did NOT Shrug! FDA Makes (Some) Comments PublicJohn MackPharma Marketing Newshttp://tr.im/Gze712/3/2009

.

Internet Communications: FDA Needs to Divide the Issues to Conquer the ProblemSteven GrossmanFDA Matters -- The Grossman FDA Reporthttp://tr.im/GzdS12/2/2009

.

A Brief Overview of the FDA Hearings on Social Media AdvertisingTony DiRestaAdvertising, Marketing & Media, Manatthttp://tr.im/HjOK12/1/2009

.

While the FDA Considers Web 2.0 Regulation, Web 3.0 is on the WayMark SenakFleishman-Hillardhttp://tr.im/GjFs12/1/2009

.

How the fda hearings help prove that social media and healthcare belong togetherJoe DoyleHC&B Healthcare Communicationshttp://tr.im/GlIm12/1/2009

.

FDA, social media and patientsSally ChurchIcarus Consultantshttp://tr.im/GeJU 11/30/2009

.

FDA's Transparency Initiative Enters The "What Is The Right Thing To Do" Phase: An Interview With Principal Deputy Commissioner SharfsteinSUBSCRIPTION REQUIREDThe Pink Sheet http://tr.im/Gmos11/30/2009

.

Who's Liable For Online Content? Pharma, Marketers Disagree (Slightly)SUBSCRIPTION REQUIREDThe Pink Sheethttp://tr.im/Gmpa11/30/2009

.

Fun with the FDAJanice Smith CollinsBrilliant Inkhttp://tr.im/FLqo11/25/2009

.

FDA Seeks to Understand Social MediaAdam SnukalReedSmith (AdLaw by Request)http://tr.im/FR9R11/25/2009

.

FDA's Emerging Internet Policy: Themes And Recommendations From Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media ToolsAreta Kupchyk, Kevin Madagan, and Paul Sheives.ReedSmith (LifeSciences Legal Update)http://tr.im/FR9f11/25/2009

.

FDA's Emerging Internet Policy: Themes And Recommendations From Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools (PDF of CLIENT ALERT)Areta Kupchyk, Kevin Madagan, and Paul Sheives.ReedSmith (LifeSciences Legal Update)http://tr.im/FRau11/25/2009

.

It’s Time for the FDA to Prohibit Direct-to-Consumer Advertising by Pharmaceutical CompaniesNAAccusourcehttp://tr.im/FHmj11/24/2009

.

Use of Social Media for Marketing Medical DevicesBarbara BixBB Marketing Plushttp://tr.im/FHTm11/24/2009

.

What We Didn't Hear at the FDA Part 15 Meeting on Social Media: PrioritiesMark SenakFleishman-Hillardhttp://tr.im/FFEp11/24/2009

.

Ongoing Debate: Social Media and Its Use in Pharma MichelleHealth Care OS Newshttp://tr.im/FGFb11/24/2009

.

FDA Questions Big Pharma's Online PresenceJohn SoatInternet Evolutionhttp://tr.im/FGCn11/24/2009

.

Linkedin and Social Media is ruining my people- feeble attempts to fight of Social Media and the Compliance nightmareNALongevity Medicinehttp://tr.im/FHmg11/24/2009

.

FDA web survey suggest social media futureSara WeinerThat Digital Stuff Bloghttp://tr.im/FHmA11/24/2009

.

Acsys Interactive President Provides Recommendations to FDA Regarding Use of Social Media in Healthcare IndustryNAAcsys Interactivehttp://tr.im/FM3d11/23/2009

.

Google's New Ad Formats for PharmaJulie BattenClickZhttp://tr.im/FBxX11/23/2009

.

What We Didn't Hear at the FDA Part 15 Meeting on Social MediaMark SenakFleishman-Hillardhttp://tr.im/FByN11/23/2009

.

The Differing Views Of Using Social Media In PharmaCliff MintzLife Science Leaderhttp://tr.im/FBxl11/23/2009

.

The FDA Grapples with Rules for Social Media (PODCAST)NAThe Burrill Report http://tr.im/FBv911/23/2009

.

Social Media Promotion Guidance Requested, But Won't Be Out SoonSUBSCRIPTION REQUIREDThe Gray Sheethttp://tr.im/Gmpy11/23/2009

.

Reporting Adverse Events Found Online Complicated By Internet's Anonymity; Can Widgets Rescue Industry From Compliance Conundrums?SUBSCRIPTION REQUIREDThe Pink Sheethttp://tr.im/GmoU11/23/2009

.

Some Internet Postings Should Be Exempt From DDMAC Clearance - SanofiSUBSCRIPTION REQUIREDThe Pink Sheethttp://tr.im/GmpH11/23/2009

.

FDA Intern & the Next Steps Toward Pharma Social Media Salvation!John MackPharma Marketing Newshttp://tr.im/Fwzd11/22/2009

.

The FDA Internet DilemmaBob EhrlichDTC Perspectiveshttp://tr.im/FoZU11/20/2009

.

Edelman Report on FDA HearingEmily DownwardEdelman PRhttp://trunc.it/3g9ml11/20/2009

.

Edelman Report on FDA Hearing (link to PDF)Emily DownwardEdelman PR http://tr.im/Fokt11/20/2009

.

After the FDA's social media hearings, what's next?Andrew TolveEyeforpharma http://tr.im/FBWF11/20/2009

.

After the FDA’s social media hearings, what’s next?Andrew TolveEyeforPharmahttp://tr.im/FnO711/20/2009

.

Future of health communications demands social media guidanceKevin BannonPR Week http://tr.im/FnNH11/20/2009

.

The FDA, Big Pharma, and Social Media: What's the Right Rx?Bob PearsonWeiscomm PRhttp://tr.im/FnYm11/20/2009

.

True confessions of a health care interactive agency head re FDA, pharma & social mediaBarbara LaveryZoo Mediahttp://tr.im/FBzQ11/20/2009

.

Why Drugmakers Don't TwitterCatherine ArnstBusiness Weekhttp://tr.im/FntH11/19/2009

.

FDA’s Hearing on Social Media – More Questions, No AnswersDara Katcher LevyHyman, Phelps & McNamara, P.C.http://tr.im/Flb211/19/2009

.

Digital Pharma: FDA listens on social mediaNAPharma Focushttp://tr.im/FlB011/19/2009

.

Key Takeaways from the FDA Internet and Social Media HearingKurt MuellerRoska Digital http://tr.im/Flcq11/19/2009

.

Pixel & Pills Interviews (VIDEO)Robert WinderVuMedihttp://tr.im/Fnu111/19/2009

.

3 Things I Learned at the FDA Social Media Hearings and 3 I Wish I HadJonathan RichmanBridge Worldwidehttp://tr.im/FeCw11/18/2009

.

Pixel & Pills Interviews (VIDEO)Mark SenakFleishman-Hillardhttp://tr.im/Fnup11/18/2009

.

A Call to Action: The FDA, Social Media and Physician EngagementJoel SelzerOzmosis http://tr.im/Feku11/18/2009

.

A Call for Social Media GuidelinesGeorge KoroneosPharmaceutical Executive http://tr.im/FheJ11/18/2009

.

FDA Hearing on Social MediaAngela RomanoSiren Interactivehttp://tr.im/FhfF11/18/2009

.

FDA Should Be Flexible in Regulating Internet Marketing of Medical ProductsNathaniel WeixelThe Bureau of National Affairs, Inc.http://tr.im/FlHN11/18/2009

.

FDA Meeting on the Internet, Social Media and Online Drug MarketingNAThe Cross-Border Biotech Bloghttp://tr.im/FntP11/18/2009

.

Pharma: Seven Tips To Improve Your Next FDA Advisory PresentationEllen HoenigBlog "Advance MarketWoRx"http://tr.im/Flor11/17/2009

.

Pixel & Pills Interviews (VIDEO)Fard JohnmarEnvision Solutionshttp://tr.im/FloJ11/17/2009

.

A feast of food for thought on social mediaTracy StatonFierce Biotechhttp://tr.im/FluW11/17/2009

.

Social media and the FDAWendy BlackburnIntouch Solutionshttp://tr.im/Flx511/17/2009

.

FDA Public Hearing Offers Forum for Industry Stakeholders to Share Comments and Suggestions Regarding Promotion Using Unique Media (CLIENT ALERT)Christina M. Marku, Elaine H. Tseng,Elizabeth T. ValentineKing & Spalding Law Practicehttp://tr.im/Hfiu11/17/2009

.

What Enterprise Can Learn From the FDA Social Media HearingsVanessa DiMauroLeader Networkshttp://tr.im/FlxB11/17/2009

.

FDA’s engagement impresses in wake of social media hearing (interview with John Kamp)Steven NilesMed Ad News http://tr.im/Fwy011/17/2009

.

Fear & Loathing in Washington, DC: Takeaways from the FDA Public Hearing (PODCAST)John Mack (host)Pharma Marketing Newshttp://tr.im/FTwn11/17/2009

.

FDA Discusses Social Media Advertising Regulation for the Life Sciences IndustryDana BlantonReed Smithhttp://tr.im/Fnu911/17/2009

.

Highlights from the FDA Hearing on Internet PromotionLeah TranAzul7http://tr.im/FlF311/16/2009

.

Pharma: Ask Not What Social Media Can Do For You but What Your SM Can Do For Patient Health.Ellen HoenigBlog "Advance MarketWoRx" http://tr.im/F78911/16/2009

.

Pixel & Pills Interviews (VIDEO)John KampCoalition for Healthcare Communicationhttp://tr.im/FlvG11/16/2009

.

Perspective on the FDA Social Media HearingBob WeissCommon Sense Media Grouphttp://tr.im/Fnv511/16/2009

.

Global lessons from FDA Social Media hearingDaniel GhinnCreation Interactivehttp://tr.im/Flw511/16/2009

.

Power To The (e) Patient!Toby BloombergDiva Marketing Bloghttp://tr.im/F5Tn11/16/2009

.

FDA public meeting on Internet promotion: regulated content meets emerging technologiesKimberly K. Egan and Rebecca Jones McKnight DLA Piperhttp://tr.im/Fnv011/16/2009

.

‘One-Click' Rule Is Not Good Regulatory PolicyJennifer HaugDTC Perspectiveshttp://tr.im/FlEv11/16/2009

.

comScore Survey: 50% of Health-Info Seekers Use Social Media to Find Health InformationJennifer HaugDTC Perspectiveshttp://tr.im/Fnui11/16/2009

.

Consumers Seek Health, Safety Information Through Online and Social Media ChannelsJennifer HaugDTC Perspectiveshttp://tr.im/FlE811/16/2009

.

Consumers Want, Expect Pharma To Participate in Social MediaJennifer HaugDTC Perspectiveshttp://tr.im/FlE211/16/2009

.

Lack of Clarity for Online Ads Creates ConfusionJennifer HaugDTC Perspectiveshttp://tr.im/FlEb11/16/2009

.

DDMAC's Abrams Promises ‘Careful' Review of PresentationsMark ToshDTC Perspectiveshttp://tr.im/FlEf11/16/2009

.

Eli Lilly Looking For More ‘Clarity' From FDAMark ToshDTC Perspectiveshttp://tr.im/FnWi11/16/2009

.

Pharma Awaits Next Steps from FDA on Social Media Mark ToshDTC Perspectiveshttp://tr.im/FlEi11/16/2009

.

Thoughts on the FDA MeetingMichael F.GSKhttp://tr.im/Fnuf11/16/2009

.

The Reality of Change: An Analysis of the November 12-13 FDA Public Hearings Christopher M. SchroederHealth Centralhttp://tr.im/FlFu11/16/2009

.

A First-Person Social View of the FDA HearingsMelissa DavieNielsenhttp://tr.im/Fnud11/16/2009

.

Patients Turn To Online Community For Help HealingJoseph ShapiroNPRhttp://tr.im/F5UX11/16/2009

.

Defying 'Gravity' with social mediaKimberly MaulPr Weekhttp://tr.im/FlCd11/16/2009

.

WOMMA Looks at the FDA Social Media HearingsJohn BellOgilvy PRhttp://tr.im/EYpf11/14/2009

.

FDA Social Media Guidelines Best Done in Baby StepsJohn MackPharma Marketing Newshttp://tr.im/Fnvd11/14/2009

.

Critics Say Social-Media Should Be Off Limits for DTC Drug AdsRich Thomaselli Ad Agehttp://tr.im/FllP11/13/2009

.

FDA Social Media Update: Will FDA Guidance Really Solve the Problem?Bio Job BloggerBio Job Bloghttp://tr.im/Flvy11/13/2009

.

Gov 2.0,The FDA, and Social MediaMarc MeyerBlog "Direct Marketing Observations"http://tr.im/Flvv11/13/2009

.

Why social media matters to FDA, Pharma and everyone elseElisheba MuturiBlog "Social Health Matters" http://tr.im/F5S811/13/2009

.

Social media are gray area for FDA regulatorsNABusiness Recordhttp://tr.im/FlQl11/13/2009

.

Pixel & Pills Interviews (VIDEO)Peter PittsCenter for Medicine in the Public Interesthttp://tr.im/FlvC11/13/2009

.

FDA Pharma Marketing Hearing Draws Big Media StakeholdersKate KayeClick Z http://tr.im/Fny511/13/2009

.

Pharmas Propose Solutions for Web Ad and Social Media RegulationsKate KayeClick Zhttp://tr.im/ES3j11/13/2009

.

FDA to Discuss Social Media Ad Regulation by Biotech IndustryMichael BarkoviakDaily Techhttp://tr.im/FlQo11/13/2009

.

A Patient’s Perspective on Day 2 of the FDA Public Hearing on Social MediaDonna R. CryerDC Patienthttp://tr.im/Flnr11/13/2009

.

An Edelman Report: Day 2 of the FDA Social Media Hearing Emily DownwardEdelman PRhttp://tr.im/F5Si11/13/2009

.

Pixel & Pills Interviews (VIDEO)Thomas Abra sFDA/DDMAChttp://tr.im/Flx911/13/2009

.

Google, Yahoo plead case at FDATracy StatonFierce Pharmahttp://tr.im/FlwW11/13/2009

.

Google Proposes to Resuscitate Paid SearchMark SenakFleishman-Hillardhttp://tr.im/EYo311/13/2009

.

Is the FDA Initiative on Transparency Over - The Part 15 Meeting and the MediaMark SenakFleishman-Hillardhttp://tr.im/Flmf11/13/2009

.

Yesterday and Today at FDA's Part 15 Meeting on Social MediaMark SenakFleishman-Hillardhttp://tr.im/Flmn11/13/2009

.

Why the FDA Needs to Accept PhRMA's Social ProposalJosh BernoffForresterhttp://tr.im/EYn411/13/2009

.

Will the FDA support or inhibit participatory health care when it comes to social media?Jane Sarasohn-KahnHealth Populihttp://tr.im/FlQs11/13/2009

.

Pixel & Pills Interviews (VIDEO)Jim Sandino and Jillian TateIntegrated Media Solutionshttp://tr.im/FlQy11/13/2009

.

FDA Considers Regulating Medical Product Information Presented in Social MediaLora BentleyIT Business Edgehttp://tr.im/FlQv11/13/2009

.

Greetings from the FDA Hearings on Social MediaMarc MonseauJNJBTW Bloghttp://tr.im/FnNN11/13/2009

.

MS&L on FDA Social Media Hearing, Friday 11/13/09MaryEllen O'Donohue and Kelly DenckeManning, Savage & Leehttp://tr.im/FlgB11/13/2009

.

FDA social media hearing, the wrapupChristiane TrueloveMed Ad Newshttp://tr.im/Fllz11/13/2009

.

Day One in DC: Industry bends FDA's ear on social mediaMatthew ArnoldMedical Marketing & Mediahttp://tr.im/Flez11/13/2009

.

Day Two in DC: Can pharma police everything online?Matthew ArnoldMedical Marketing & Mediahttp://tr.im/Flo311/13/2009

.

Industry Urges Online-Specific Rules for Adverse Event ReportsEmily P. WalkerMedPage Todayhttp://tr.im/Flm011/13/2009

.

Social Media Rx for Drug SafetyAliya SilversteinNext Govhttp://tr.im/FlBK11/13/2009

.

Nielsen Podcast: The FDA, Pharma and Social Media (PODCAST)Melissa DavieNielsenhttp://tr.im/ES0l11/13/2009

.

7 Significant Presentations From Day 1 Of The FDA HearingsRohit BhargavaOgilvy PRhttp://tr.im/Fldi11/13/2009

.

Pixel & Pills Interviews (VIDEO)Rohit BhargavaOgilvy PR http://tr.im/FnNT11/13/2009

.

FDA Hearing Is all 'aTwitter' Over Internet Advertising RulesNAPharmacy Choicehttp://tr.im/FlQB11/13/2009

.

What Happened on Day 1 of the FDA Hearings – Our Quick and Easy SummaryKimberley IrishPixel & Pillshttp://tr.im/Fnvn11/13/2009

.

Ogilvy's John Bell: FDA Social Media Guidelines Will "Basically Follow Same Process" As FTC Blogging GuidelinesJoe CiaralloPR Newserhttp://tr.im/FlQH11/13/2009

.

FDA Takes On Social Media Drug PromotionNAReutershttp://tr.im/FlQJ11/13/2009

.

FDA Social Meeting Day 2 Afternoon TakeawaysKurt MuellerRoska Digitalhttp://tr.im/FlmZ11/13/2009

.

FDA Social Meeting Safety Early Morning Key PointsKurt MuellerRoska Digitalhttp://tr.im/EYo011/13/2009

.

FDA Social Meeting Safety Late Morning Key PointsKurt MuellerRoska Digital http://tr.im/Flmz11/13/2009

.

Pharma companies seek US FDA guidelines on social media promotion Sue SutterSCRIPhttp://tr.im/FlQK11/13/2009

.

Current FDA Regulations Reflect a Pre-Web Communications ParadigmLarry WeberW2 Grouphttp://tr.im/FlBR11/13/2009

.

Pharma Takes Its Fingers Out of Its Ears; Is the FDA Listening? (Day 2 of #FDASM)Heather SnowWaggener Edstromhttp://tr.im/Fln911/13/2009

.

Google’s Pitch to FDA for Online Drug AdsJacob GoldsteinWall Street Journal (Blog)http://tr.im/FlD011/13/2009

.

Pixel & Pills Interviews (VIDEO)Jack BarretteWego Healthhttp://tr.im/FlpS11/13/2009

.

Day One of the FDA Hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social MediaBarbara LaveryZoomediahttp://tr.im/Fnvf11/13/2009

.

PhRMA Proposes FDA-Approved Logo for Marketing in Social MediaRich THomaselliAd Agehttp://tr.im/EXPa11/12/2009

.

Pharma & Social Media (VIDEO)Mike HuckmanCNBChttp://tr.im/ERz611/12/2009

.

A Patient’s Perspective on Day 1 of the FDA Public Hearing on Social MediaDonna R. CryerDC Patienthttp://tr.im/ERxZ11/12/2009

.

An Edelman Report: Day 1 of the FDA Social Media Hearing Emily DownwardEdelman PRhttp://tr.im/ERwx11/12/2009

.

A Disturbing Signal at FDA Social Media ConferenceMark SenakFleishman-Hillardhttp://tr.im/Flef11/12/2009

.

Lilly Hits One Out of the BallparkMark SenakFleishman-Hillardhttp://tr.im/Flej11/12/2009

.

Making health-related ads more usefulPablo ChavezGooglehttp://tr.im/ERIn11/12/2009

.

Pixel & Pills Interviews (VIDEO)MK TatumHeartbeat Digital http://tr.im/FlLl11/12/2009

.

Pixel & Pills Interviews (VIDEO)Matthew WhalenImpact, LLC http://tr.im/FlLs11/12/2009

.

Pixel & Pills Interviews (VIDEO)Jay BryantLive Worldhttp://tr.im/FlpW11/12/2009

.

MS&L on FDA Social Media Hearing, Thursday 11/12/09MaryEllen O'Donohue and Kelly DenckeManning, Savage & Leehttp://tr.im/Flgt11/12/2009

.

Day 1 of pharma social media hearings, after the morningChristiane TrueloveMed Ad Newshttp://tr.im/Flgl11/12/2009

.

FDA Begins to Shape Rules for Online Drug, Device AdsEmily P. WalkerMedPage Today http://tr.im/FlLy11/12/2009

.

FDA Tackles Drugmaker Talk On Facebook, Twitter And GoogleScott HensleyNPRhttp://tr.im/FldK11/12/2009

.

Inside the FDA Hearing: 3 Key Takeaways From Day 1Rohit BhargavaOgilvy PRhttp://tr.im/Fldc11/12/2009

.

FDA ponders drug ads on Twitter, et alNAP2P Net Newshttp://tr.im/Flwk11/12/2009

.

Pixel & Pills Interviews (VIDEO)John MackPharma Marketing Newshttp://tr.im/FlQg11/12/2009

.

US PhRMA calls for FDA internet info safety logoLynne TaylorPharma Timeshttp://tr.im/FlFq11/12/2009

.

FDA tackles gray area of social mediaDeepa SeetharamanReutershttp://tr.im/FlQj11/12/2009

.

U.S. FDA seeks input on possible Internet rulesDeepa SeetharamanReutershttp://tr.im/Flff11/12/2009

.

FDA Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media – Webcast and TestimonyThomas SullivanRockpointe Corporationhttp://tr.im/ES3J11/12/2009

.

FDA Social Meeting Day 1 Early PM SummaryKurt MuellerRoska Digitalhttp://tr.im/Fldw11/12/2009

.

Pixel & Pills Interviews (VIDEO)Diane ZuckermanThe National Research Center for Women and Familieshttp://tr.im/FloE11/12/2009

.

The FDA Gets Social: To Tweet or Not to Tweet and What of Adverse Events? (Day 1 of #FDASM)Heather SnowWaggener Edstromhttp://tr.im/FlcR11/12/2009

.

Drug Makers to Press for Guidance on Web MarketingEmily SteelWall Street Journalhttp://tr.im/FleG11/12/2009

.

FDA: Twas the Night Before #fdasmEllen HoenigBlog "Advance MarketWoRx"http://tr.im/ES3G11/11/2009

.

A (Hypothetical) Letter to Consumers from PharmaWendy BlackburnIntouch Solutionshttp://tr.im/EJ8f11/10/2009

.

166 Reportable Adverse Events Equals One Red HerringJonathan Richmanhttp://tr.im/F5Si11/10/2009

.

FDA hearing on social media - first hole in the wall?Silja ChouquetWhyDotPharmahttp://tr.im/EC1P11/9/2009

.

FDA Social Media Hearings -- Output Might Confuse ConsumersKurt MuellerRoska Digitalhttp://tr.im/ES3A11/4/2009

.

Economist Special Report "Digital Medicine" April, 2009Vijay ViswanathanThe Economisthttp://tr.im/F5Se 4/16/2009